Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.

@article{Hirose2005AripiprazoleAN,
  title={Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.},
  author={Tsuyoshi Hirose and Tetsuro Kikuchi},
  journal={The journal of medical investigation : JMI},
  year={2005},
  volume={52 Suppl},
  pages={284-90}
}
It is obvious that DA is an important neurotransmitter in vivo. It is involved in a variety of physiological processes such as mental processes, motor function and hormone regulation. In this context, it is quite understandable that a DA D2 receptor antagonist that inhibits the DA D2 receptor regardless of the state of activity of dopaminergic neurotransmission and inhibit the physiological function of DA can have a variety of adverse effects. In contrast to DA D2 antagonists, aripiprazole acts… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Calculating occupancy when one does not have baseline: a comparison of different options.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism • 2011
View 1 Excerpt
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Altar CA : In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

S Jordan, V Koprivica, DunnR, K Tottori, T Kikuchi
Eur J Phamacol • 2004
View 2 Excerpts

Aripiprazole ; a review of its use in schizophrenia and schizoaffective disorder

TS Harrison, CM Perry
Drugs • 2004

CM:Aripiprazole;a review of its use in schizophrenia and schizoaffective disorder

TS Harrison, Perry
Drugs • 2004
View 1 Excerpt

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

S Jordan, DunnR Koprivica V, K Tottori, T Kikuchi, CA Altar
Eur J Phamacol • 2004

Information of the latest antipsychotic : aripiprazole

S Miyamoto
The Japanese Journal of Psychiatry • 2004

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side - effect profile

UwahodoY HiroseT, MiwaT YamadaS, +4 authors T Nabeshima
J Psycho - pharmacol • 2004

Novelty of aripiprazole : a new dopamine D2 receptor partial agonist for the treatment of schizophrenia

M Nagashi
Clinical Psychiatry • 2004

Similar Papers

Loading similar papers…